The severe increases in cholesterol, triglycerides, fasting blood glucose, and the reduction in insulin levels support the conclusion that this mouse model effectively represents key aspects of obesity, metabolic syndrome, and Type 2 diabetes. This evidence concerns the gene INS and obesity disorder.